PMID- 29907582
OWN - NLM
STAT- MEDLINE
DCOM- 20180927
LR  - 20181004
IS  - 1935-5548 (Electronic)
IS  - 0149-5992 (Linking)
VI  - 41
IP  - 8
DP  - 2018 Aug
TI  - Social Network Characteristics Are Associated With Type 2 Diabetes Complications: 
      The Maastricht Study.
PG  - 1654-1662
LID - 10.2337/dc17-2144 [doi]
AB  - OBJECTIVE: The relation between clinical complications and social network 
      characteristics in type 2 diabetes mellitus (T2DM) has hardly been studied. 
      Therefore, we examined the associations of social network characteristics with 
      macro- and microvascular complications in T2DM and investigated whether these 
      associations were independent of glycemic control, quality of life, and 
      well-known cardiovascular risk factors. RESEARCH DESIGN AND METHODS: Participants 
      with T2DM originated from the Maastricht Study, a population-based cohort study 
      (n = 797, mean age 62.7 +/- 7.6 years, 31% female). Social network characteristics 
      were assessed through a name generator questionnaire. Diabetes status was 
      determined by an oral glucose tolerance test. Macro- and microvascular 
      complications were defined as a history of cardiovascular disease and the 
      presence of impaired vibratory sense and/or retinopathy and/or albuminuria, 
      respectively. We assessed cross-sectional associations of social network 
      characteristics with macro- and microvascular complications by use of logistic 
      regression adjusted for age, HbA(1c), quality of life, and cardiovascular risk 
      factors, stratified for sex. RESULTS: A smaller network size, higher percentages 
      of family members, and lower percentages of friends were independently associated 
      with macrovascular complications in both men and women. A smaller network size 
      and less informational support were independently associated with microvascular 
      complications in women, but not in men. CONCLUSIONS: This study shows that social 
      network characteristics were associated with macro- and microvascular 
      complications. Health care professionals should be aware of the association of 
      the social network with T2DM outcomes. In the development of strategies to reduce 
      the burden of disease, social network characteristics should be taken into 
      account.
CI  - (c) 2018 by the American Diabetes Association.
FAU - Brinkhues, Stephanie
AU  - Brinkhues S
AUID- ORCID: 0000-0003-2471-7033
AD  - Department of Medical Microbiology, Maastricht University Medical Centre, 
      Maastricht, the Netherlands.
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Sexual Health, Infectious Diseases, and Environmental Health, 
      Public Health Service South Limburg, Heerlen, the Netherlands.
FAU - Dukers-Muijrers, Nicole H T M
AU  - Dukers-Muijrers NHTM
AD  - Department of Medical Microbiology, Maastricht University Medical Centre, 
      Maastricht, the Netherlands.
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Sexual Health, Infectious Diseases, and Environmental Health, 
      Public Health Service South Limburg, Heerlen, the Netherlands.
FAU - Hoebe, Christian J P A
AU  - Hoebe CJPA
AD  - Department of Medical Microbiology, Maastricht University Medical Centre, 
      Maastricht, the Netherlands.
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Sexual Health, Infectious Diseases, and Environmental Health, 
      Public Health Service South Limburg, Heerlen, the Netherlands.
FAU - van der Kallen, Carla J H
AU  - van der Kallen CJH
AD  - Department of Medicine, Maastricht University Medical Centre, Maastricht, the 
      Netherlands.
AD  - Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 
      Maastricht, the Netherlands.
FAU - Koster, Annemarie
AU  - Koster A
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Social Medicine, Maastricht University, Maastricht, the 
      Netherlands.
FAU - Henry, Ronald M A
AU  - Henry RMA
AD  - Department of Medicine, Maastricht University Medical Centre, Maastricht, the 
      Netherlands.
AD  - Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 
      Maastricht, the Netherlands.
FAU - Stehouwer, Coen D A
AU  - Stehouwer CDA
AD  - Department of Medicine, Maastricht University Medical Centre, Maastricht, the 
      Netherlands.
AD  - Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 
      Maastricht, the Netherlands.
FAU - Savelkoul, Paul H M
AU  - Savelkoul PHM
AD  - Department of Medical Microbiology, Maastricht University Medical Centre, 
      Maastricht, the Netherlands.
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Medical Microbiology and Infection Control, VU University Medical 
      Center, Amsterdam, the Netherlands.
FAU - Schaper, Nicolaas C
AU  - Schaper NC
AD  - Care and Public Health Research Institute (CAPHRI), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Department of Medicine, Maastricht University Medical Centre, Maastricht, the 
      Netherlands.
AD  - Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 
      Maastricht, the Netherlands.
FAU - Schram, Miranda T
AU  - Schram MT
AUID- ORCID: 0000-0001-8113-7604
AD  - Department of Medicine, Maastricht University Medical Centre, Maastricht, the 
      Netherlands m.schram@maastrichtuniversity.nl.
AD  - Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 
      Maastricht, the Netherlands.
AD  - Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, the 
      Netherlands.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20180615
PL  - United States
TA  - Diabetes Care
JT  - Diabetes care
JID - 7805975
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Blood Glucose/metabolism
MH  - Cardiovascular Diseases/epidemiology/etiology/psychology
MH  - Cohort Studies
MH  - Cross-Sectional Studies
MH  - Diabetes Complications/*epidemiology/*etiology/psychology
MH  - Diabetes Mellitus, Type 2/blood/*complications/*epidemiology/psychology
MH  - Diabetic Nephropathies/epidemiology/etiology/psychology
MH  - Female
MH  - Glucose Tolerance Test
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Netherlands/epidemiology
MH  - Quality of Life
MH  - Risk Factors
MH  - *Social Support
EDAT- 2018/06/17 06:00
MHDA- 2018/09/28 06:00
CRDT- 2018/06/17 06:00
PHST- 2017/10/12 00:00 [received]
PHST- 2018/05/14 00:00 [accepted]
PHST- 2018/06/17 06:00 [pubmed]
PHST- 2018/09/28 06:00 [medline]
PHST- 2018/06/17 06:00 [entrez]
AID - dc17-2144 [pii]
AID - 10.2337/dc17-2144 [doi]
PST - ppublish
SO  - Diabetes Care. 2018 Aug;41(8):1654-1662. doi: 10.2337/dc17-2144. Epub 2018 Jun 
      15.